Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.35 INR | +1.30% | +3.31% | -36.61% |
11/06 | Evoq Remedies Limited announced that it expects to receive INR 192.1 million in funding | CI |
27/05 | Evoq Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Sales 2022 | 168M 2.01M | Sales 2023 | 264M 3.17M | Capitalization | 177M 2.12M |
---|---|---|---|---|---|
Net income 2022 | 10M 120K | Net income 2023 | 16M 192K | EV / Sales 2022 | 2.13 x |
Net Debt 2022 | 50.64M 607K | Net Debt 2023 | 94.23M 1.13M | EV / Sales 2023 | 1.03 x |
P/E ratio 2022 |
20.7
x | P/E ratio 2023 |
10.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.44% |
1 day | +1.30% | ||
1 week | +3.31% | ||
Current month | -1.37% | ||
1 month | -8.96% | ||
3 months | -16.89% | ||
6 months | -24.90% | ||
Current year | -36.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 42 | 03/02 | |
Yogesh M. Rajput
DFI | Director of Finance/CFO | - | 12/22/12 |
Compliance Officer | 36 | 03/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 11/23/11 | |
Director/Board Member | 32 | 03/22/03 | |
Director/Board Member | 30 | 03/22/03 |
Date | Price | Change | Volume |
---|---|---|---|
12/24/12 | 9.35 | +1.30% | 8,000 |
11/24/11 | 9.23 | -1.18% | 4,000 |
10/24/10 | 9.34 | +2.19% | 128,000 |
07/24/07 | 9.14 | +0.33% | 12,000 |
06/24/06 | 9.11 | -4.11% | 28,000 |
Delayed Quote Bombay S.E., June 12, 2024 at 03:30 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-36.61% | 1.5M | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-3.92% | 159B |
- Stock Market
- Equities
- 543500 Stock